Crossmark Global Holdings, Inc. Becton Dickinson & CO Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 10,987 shares of BDX stock, worth $2.46 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,987

Previous 10,790 1.83%

Holding current value

$2.46 Million

Previous $2.52 Million 5.04%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$221.47 - $242.41 $43,629 - $47,754	197 Added 1.83%	10,987 $2.65 Million
Q2 2024 Jul 29, 2024	SELL	$225.07 - $246.17 $100,381 - $109,791	-446 Reduced 3.97%	10,790 $2.52 Million
Q1 2024 May 13, 2024	SELL	$233.45 - $247.73 $410,171 - $435,261	-1,757 Reduced 13.52%	11,236 $2.78 Million
Q4 2023 Feb 13, 2024	SELL	$232.24 - $267.23 $128,893 - $148,312	-555 Reduced 4.1%	12,993 $3.17 Million
Q3 2023 Nov 08, 2023	SELL	$254.9 - $283.59 $12.5 Million - $13.9 Million	-49,045 Reduced 78.36%	13,548 $3.62 Million
Q2 2023 Jul 31, 2023	SELL	$238.39 - $265.32 $41,718 - $46,431	-175 Reduced 0.28%	62,593 $17.5 Million
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $10.9 Million - $12.3 Million	47,454 Added 309.87%	62,768 $15.5 Million
Q4 2022 Jan 19, 2023	SELL	$218.29 - $256.91 $7.29 Million - $8.58 Million	-33,390 Reduced 68.56%	15,314 $3.89 Million
Q3 2022 Nov 01, 2022	BUY	$51.03 - $264.23 $1.75 Million - $9.07 Million	34,337 Added 239.0%	48,704 $10.9 Million
Q2 2022 Jul 29, 2022	BUY	$234.74 - $275.42 $89,201 - $104,659	380 Added 2.72%	14,367 $3.54 Million
Q1 2022 May 11, 2022	BUY	$243.64 - $270.48 $34,840 - $38,678	143 Added 1.03%	13,987 $3.72 Million
Q4 2021 Jan 10, 2022	BUY	$230.08 - $250.94 $147,251 - $160,601	640 Added 4.85%	13,844 $3.48 Million
Q3 2021 Oct 21, 2021	BUY	$232.72 - $256.47 $3.07 Million - $3.39 Million	13,204 New	13,204 $3.25 Million
Q3 2021 Oct 13, 2021	SELL	$232.72 - $256.47 $3.06 Million - $3.37 Million	-13,158 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$232.65 - $254.58 $84,917 - $92,921	365 Added 2.85%	13,158 $3.2 Million
Q1 2021 Apr 15, 2021	SELL	$232.09 - $256.88 $171,978 - $190,348	-741 Reduced 5.48%	12,793 $3.11 Million
Q4 2020 Jan 14, 2021	SELL	$221.92 - $245.94 $33,288 - $36,891	-150 Reduced 1.1%	13,534 $3.39 Million
Q3 2020 Oct 08, 2020	SELL	$215.77 - $276.76 $51,353 - $65,868	-238 Reduced 1.71%	13,684 $3.18 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $167,343 - $200,455	761 Added 5.78%	13,922 $3.33 Million
Q1 2020 Apr 28, 2020	SELL	$195.69 - $279.01 $123,676 - $176,334	-632 Reduced 4.58%	13,161 $2.95 Million
Q4 2019 Feb 06, 2020	SELL	$236.45 - $266.82 $157,475 - $177,702	-666 Reduced 4.61%	13,793 $3.75 Million
Q3 2019 Oct 09, 2019	SELL	$230.58 - $256.08 $358,782 - $398,460	-1,556 Reduced 9.72%	14,459 $3.66 Million
Q2 2019 Jul 09, 2019	BUY	$217.4 - $246.08 $88,047 - $99,662	405 Added 2.59%	16,015 $4.04 Million
Q1 2019 May 02, 2019	SELL	$206.05 - $248.17 $350,903 - $422,633	-1,703 Reduced 9.84%	15,610 $3.9 Million
Q4 2018 Jan 31, 2019	SELL	$204.73 - $257.93 $739,484 - $931,643	-3,612 Reduced 17.26%	17,313 $3.9 Million
Q3 2018 Nov 08, 2018	SELL	$233.07 - $256.0 $518,813 - $569,856	-2,226 Reduced 9.62%	20,925 $5.46 Million
Q2 2018 Jul 31, 2018	SELL	$208.1 - $233.85 $646,982 - $727,039	-3,109 Reduced 11.84%	23,151 $5.55 Million
Q1 2018 Apr 16, 2018	SELL	$205.46 - $240.27 $742,121 - $867,855	-3,612 Reduced 12.09%	26,260 $5.69 Million
Q4 2017 Feb 05, 2018	BUY	$189.0 - $222.64 $1.09 Million - $1.29 Million	5,785 Added 24.02%	29,872 $6.39 Million
Q3 2016 Oct 25, 2017	BUY	N/A	24,087	24,087 $4.72 Million

Others Institutions Holding BDX

# of Institutions

1,739

Shares Held

251M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Becton Dickinson & CO Transaction History